BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 30, Issue 1
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (19011)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.
Item 
Count 
PDF445
WORD37
HTML15245
Figures (1-3)828
Tables (1-2)649
 Sum=17204
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse194
Download719
 Sum=913
Jan 7, 2024 (publication date) through Jan 6, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Srinivasan AR. Treat to target in Crohn’s disease: A practical guide for clinicians. World J Gastroenterol 2024; 30(1): 50-69 [PMID: 38293329 DOI: 10.3748/wjg.v30.i1.50]
URL: https://www.wjgnet.com/1007-9327/full/v30/i1/50.htm
Number Citing Articles
1
Jelena Pilipovic Grubor, Sanja Stojanovic, Dijana Niciforovic, Marijana Basta Nikolic, Zoran D. Jelicic, Mirna N. Radovic, Jelena Ostojic. Beyond Fixed Thresholds: Cluster-Derived MRI Boundaries Improve Assessment of Crohn’s Disease Activity. Journal of Clinical Medicine 2025; 14(21): 7523 doi: 10.3390/jcm14217523
2
Jun Lu, Hui Xu, Jingxuan Zhang, Tianxin Cheng, Jing Zheng, Xinjun Han, Yuxin Wang, Xuxu Meng, Xiaoyang Li, Jiahui Jiang, Xue Dong, Zhenchang Wang, Zhenghan Yang, Lixue Xu. The CT-based attenuation index of peri-bowel adipose tissue can predict disease progression in inflammatory bowel disease patients. European Radiology 2025;  doi: 10.1007/s00330-025-12079-x
3
James D. Lewis, Aisha Vadhariya, Sylvia Su, Xian Zhou, Frederick Durand, Ariane K. Kawata, Larissa Stassek, Claudine Clucas, Stefan Schreiber. A patient-reported outcome measure comprising the stool frequency and abdominal pain items from the Crohn’s Disease Activity Index: psychometric evaluation in adults with Crohn’s disease. Journal of Patient-Reported Outcomes 2025; 9(1) doi: 10.1186/s41687-025-00851-y
4
Joana Mota, Maria João Almeida, Francisco Mendes, Miguel Martins, Tiago Ribeiro, João Afonso, Pedro Cardoso, Helder Cardoso, Patricia Andrade, João Ferreira, Guilherme Macedo, Miguel Mascarenhas. A Comprehensive Review of Artificial Intelligence and Colon Capsule Endoscopy: Opportunities and Challenges. Diagnostics 2024; 14(18): 2072 doi: 10.3390/diagnostics14182072
5
Xiao Han, Jinghan Liu, Jinli Bu, Zhen Wang, Zhouying Chen, Meihao Wei. Impact of sense of coherence and social support on disease activity in Crohn’s disease: a network analysis. Frontiers in Public Health 2025; 13 doi: 10.3389/fpubh.2025.1701461
6
Saifei Xu, Pingnan Zhang, Na Li, Jingjing Liu, Xiaotan Dou, Chenggong Yu. IFX Is Associated with Higher Rates of 2-Year Mucosal Healing in Biologic-Naïve CD Patients Compared to UST. Digestive Diseases and Sciences 2025; 70(12): 4235 doi: 10.1007/s10620-025-09226-1
7
Joana Mota, Maria João Almeida, Miguel Martins, Francisco Mendes, Pedro Cardoso, João Afonso, Tiago Ribeiro, João Ferreira, Filipa Fonseca, Manuel Limbert, Susana Lopes, Guilherme Macedo, Fernando Castro Poças, Miguel Mascarenhas. Artificial Intelligence in Coloproctology: A Review of Emerging Technologies and Clinical Applications. Journal of Clinical Medicine 2024; 13(19): 5842 doi: 10.3390/jcm13195842
8
Mohamed S. Elgendy, Ahmed Raza, Mohamed Rifai, Wajeeh Ur Rehman, Ahmed Emara, Muhammad Haris Khan, Ayiz Jan, Muhammad Younas, Anum Nawaz, Ubaid Khan. Dose-dependent efficacy and safety of Filgotinib in moderate to severe Crohn’s disease: a grade-assessed systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Pharmacology 2025; 81(10): 1517 doi: 10.1007/s00228-025-03891-x
9
Richard W Lo, Gauraang Bhatnagar, Numan Kutaiba, Ashish R Srinivasan. Evaluating luminal and post-operative Crohn’s disease activity on magnetic resonance enterography: A review of radiological disease activity scores. World Journal of Gastroenterology 2025; 31(26): 107419 doi: 10.3748/wjg.v31.i26.107419
10
Sarah El-Nakeep. The intestinal ultrasound role in inflammatory bowel disease in clinical practice and a critical appraisal of the current guidelines (mini-review). The Egyptian Journal of Internal Medicine 2024; 36(1) doi: 10.1186/s43162-024-00316-6
11
Fabrizio Fanizzi, Ferdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese, Axel Dignass. Treatment targets in IBD: is it time for new strategies?. Best Practice & Research Clinical Gastroenterology 2025; 77: 101990 doi: 10.1016/j.bpg.2025.101990
12
Justyna Lorenc-Góra, Dariusz Waniczek, Zenon P. Czuba, Mariusz Kryj, Zbigniew Lorenc, Małgorzata Muc-Wierzgoń. Assessment of the Utility of Selected Inflammatory Markers in Correlation with Magnetic Resonance Enterography (MRE) Findings in the Diagnosis of Crohn’s Disease. Biomolecules 2025; 15(1): 116 doi: 10.3390/biom15010116
13
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
14
Habeeb Habeeb, Lynna Chen, Isabelle De Kock, Gauraang Bhatnagar, Numan Kutaiba, Abhinav Vasudevan, Ashish R Srinivasan. Imaging in perianal fistulising Crohn’s disease: A practical guide for the gastroenterologist. World Journal of Gastroenterology 2025; 31(34): 110611 doi: 10.3748/wjg.v31.i34.110611
15
Ashish Srinivasan, Daniel van Langenberg, Peter De Cruz, Jonathan Segal, Abhinav Vasudevan, Richard N. Upton. Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation Study. BioDrugs 2024; 38(5): 691 doi: 10.1007/s40259-024-00673-2
16
Giulia Migliorisi, Elisabetta Mastrorocco, Arianna Dal Buono, Roberto Gabbiadini, Gaia Pellegatta, Paola Spaggiari, Francesca Racca, Enrico Heffler, Edoardo Vincenzo Savarino, Cristina Bezzio, Alessandro Repici, Alessandro Armuzzi. Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review. Journal of Clinical Medicine 2024; 13(14): 4119 doi: 10.3390/jcm13144119
17
Pedro Vilela Teixeira, Rolando Pinho, Pedro Mesquita, Catarina Costa, Rita Ferreira, Ana Ponte, Adélia Rodrigues, Teresa Freitas. External Validation of a Capsule Endoscopy Scoring System (CESS-CD) for Early Crohn�s Disease Diagnosis. Revista Española de Enfermedades Digestivas 2025;  doi: 10.17235/reed.2025.11555/2025
18
Priyanka Raju Chougule, Sukesh Narayan Sinha. Next-generation non-animal models for inflammatory bowel disease: In vitro and in silico approaches for mechanistic understanding. NAM Journal 2025; 1: 100051 doi: 10.1016/j.namjnl.2025.100051
19
Shintaro Nakao, Sentaro Kusuhara, Tomoaki Murakami. Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology. Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262(12): 3749 doi: 10.1007/s00417-024-06558-y
20
Francisca Carvajal, Karin Herrera, Paulina Núñez, Lilian Flores, Andrea Córdova, Gonzalo Pizarro, Pamela San Martín, Rodrigo Quera. Challenges in adherence to STRIDE-II: Perspectives from gastroenterologists and patients with inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 2025; 48(9): 502440 doi: 10.1016/j.gastre.2025.502440
21
Krishneel Dutt, Abhinav Vasudevan, Alexander Hodge, Tuan L Nguyen, Ashish R Srinivasan. Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review. World Journal of Gastroenterology 2025; 31(24): 107661 doi: 10.3748/wjg.v31.i24.107661
22
Yasser Ali Khoshaim, Yahya Z. Habis, Afnan Ghazi Daqnah, Razan Khalid Alqurashi, Yazeed Shaker Abdulrahim, Abdullah Sakkat, Sultan Ali Alsubhi, Deema Tawfeq Almuwlad, Halah Samer Bukhari, Abdulrhman J. Shogdar, Omar Ashraf Amir, Mohamed Sayed Zaazouee. Filgotinib in Moderate-to-Severe Crohn’s Disease: A Network Meta-Analysis of Efficacy and Adverse Events. Healthcare 2025; 14(1): 5 doi: 10.3390/healthcare14010005
23
David T Rubin, Ailsa L Hart. A Guide to the Patient-Centric Use of Vedolizumab for Crohn’s Disease. Inflammatory Bowel Diseases 2025; 31(8): 2269 doi: 10.1093/ibd/izaf072
24
Laura Parisio, Angelo Del Gaudio, Jacopo Iaccarino, Pierluigi Puca, Guia Becherucci, Gaetano Coppola, Carlo Covello, Federica Di Vincenzo, Elisa Foscarini, Lucrezia Laterza, Letizia Masi, Marco Pizzoferrato, Francesca Profeta, Daniela Pugliese, Valentina Petito, Marcello Chieppa, Giammarco Mocci, Giovanni Cammarota, Antonio Gasbarrini, Loris Riccardo Lopetuso, Marcello Covino, Franco Scaldaferri, Alfredo Papa. Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn’s Disease: A Prospective Study. Journal of Clinical Medicine 2025; 14(17): 6337 doi: 10.3390/jcm14176337
25
Ebru Ar, Irini Solomonidou, Henrike Lenzen, Miriam Wiestler, Claudia Veltkamp, Katharina Willuweit, Jassin Rashidi-Alavijeh, Hartmut H. Schmidt, Richard Vollenberg, Phil-Robin Tepasse, Jonel Trebicka, Stefanie Tischendorf, Carsten Elfers, Karim Hamesch, Arne Bokemeyer. Long-Term Clinical and Endoscopic Outcomes of Crohn’s Disease Following Liver Transplantation: A Multicenter Cohort Study. Biomedicines 2025; 13(9): 2200 doi: 10.3390/biomedicines13092200
26
Hongsai Hu, Rong He, Minji Liu, Hongbing Zhou, Lin Tan, Qiongjia Ai, Qian Wang, Luwei Zeng, Weiming Qu. C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn’s Disease. International Journal of General Medicine 2024; : 6219 doi: 10.2147/IJGM.S487505
27
Francisca Carvajal, Karin Herrera, Paulina Núñez, Lilian Flores, Andrea Córdova, Gonzalo Pizarro, Pamela San Martín, Rodrigo Quera. Desafíos en la adherencia a STRIDE-II: perspectivas de gastroenterólogos y pacientes con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2025; 48(9): 502440 doi: 10.1016/j.gastrohep.2025.502440
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345